Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07448402
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of psoriatic disease, including psoriasis (any clinical variant) and/or psoriatic arthritis based on rheumatologic criteria.
* Receiving IL-23 inhibitor therapy (guselkumab or risankizumab).
* Treated within participating Costa Rican public health centers.
* Availability of sufficient clinical records to complete registry data (history, follow-up, labs).
* Age ≥12 years, any sex.
Exclusion Criteria:
* None specified (all patients meeting inclusion criteria are eligible).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT07448402
Study Brief:
Protocol Section:
NCT07448402